Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003;4(3):E34.
doi: 10.1208/pt040334.

Preparation of biodegradable microspheres and matrix devices containing naltrexone

Rassoul Dinarvand  1 , Shadi H Moghadam, Leyla Mohammadyari-Fard, Fatemeh Atyabi
Affiliations

Preparation of biodegradable microspheres and matrix devices containing naltrexone

Rassoul Dinarvand et al. AAPS PharmSciTech. 2003.

Abstract

In this study, the use of biodegradable polymers for microencapsulation of naltrexone using solvent evaporation technique is investigated. The use of naltrexone microspheres for the preparation of matrix devices is also studied. For this purpose, poly(L-lactide) (PLA) microspheres containing naltrexone prepared by solvent evaporation technique were compressed at temperatures above the Tg of the polymer. The effect of different process parameters, such as drug/polymer ratio and stirring rate during preparation of microspheres, on the morphology, size distribution, and in vitro drug release of microspheres was studied. As expected, stirring rate influenced particle size distribution of microspheres and hence drug release profiles. By increasing the stirring speed from 400 to 1200 rpm, the mean diameter of microspheres decreased from 251 microm to 104 microm. The drug release rate from smaller microspheres was faster than from larger microspheres. However, drug release from microspheres with low drug content (20% wt/wt) was not affected by the particle size of microspheres. Increasing the drug content of microspheres from 20% to 50% wt/wt led to significantly faster drug release from microspheres. It was also shown that drug release from matrix devices prepared by compression of naltrexone microspheres is much slower than that of microspheres. No burst release was observed with matrix devices. Applying higher compression force, when compressing microspheres to produce tablets, resulted in lower drug release from matrix devices. The results suggest that by regulating different variables, desired release profiles of naltrexone can be achieved using a PLA microparticulate system or matrix devices.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bullingham RE, McQuay HJ, Moore RA. Clinical pharmacokinetics of narcotic agonist-antagonist drugs. Clin Pharmacokinet. 1983;8:332–343. doi: 10.2165/00003088-198308040-00004. - DOI - PubMed
    1. Way WL, Fields HL, Way EL. Opioid analgesics and antagonists. In: Katzung BG, editor. Basic and Clinical Pharmacology. 7th ed. Norwalk, CN: Appleton and Lange; 1998. pp. 512–513.
    1. Chiang CN, Holister LE, Kishimoto A, Barnett G. Kinetics of naltrexone, sustained release preparations. Int J Clin Pharmacol Ther. 1984;36:704–708. - PubMed
    1. Wise DL. Controlled release for use in treatment of narcotic addiction. In: Langer RS, Wise DL, editors. Medical Application of Controlled Release. Boca Raton, FL: CRC Press; 1984. pp. 108–112.
    1. Physicians Desk Reference. 53rd ed. Montvale, NJ: Medical Economics Co Inc; 1999. Production Information: Trexan; pp. 936–938.

Publication types

LinkOut - more resources